The Chronic Lymphocytic Leukemia Channel on VJHemOnc is an independent medical education platform, supported with funding from AstraZeneca (Diamond), AbbVie (Platinum), BeOne Medicines (Silver) and Lilly (Silver). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
ERIC 2024 | The potential of targeting non-malignant cells in the CLL microenvironment
Martina Seiffert, PhD, German Cancer Research Center, Heidelberg, Germany, discusses the complex microenvironment in chronic lymphocytic leukemia (CLL). She emphasizes the potential of targeting not only malignant cells but also the neighboring cells. This interview took place at the 2024 European Research Initiative on CLL (ERIC) Meeting in Barcelona, Spain.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
